Makondo Shimukowa, MD
Infectious Disease · Delmar, DENPI 1730389982
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $416 and has fallen 58.6% since, to $172 in 2025.
Across 75 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$350
- Gilead$340
- Merck$220
- Viiv Healthcare Company$183
- Johnson & Johnson$127
- Ferring Pharmaceuticals Inc.$85
- plus $356 from 12 others
What the payments were for
- Food & beverage$1,52792%
- Education$1338%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 10 | $350 |
| Gilead | 13 | $340 |
| Merck | 13 | $220 |
| Viiv Healthcare Company | 9 | $183 |
| Johnson & Johnson(2 entities) | 8 | $127 |
| Ferring Pharmaceuticals Inc. | 4 | $85 |
| AstraZeneca | 3 | $67 |
| Theratechnologies Inc. | 3 | $40 |
| AbbVie | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Lundbeck LLC | 1 | $35 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Exact Sciences | 1 | $23 |
| Shionogi Inc | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Biktarvy$125
How this compares
$1,661 in reported general payments places this provider in the 70th percentile of 28 infectious disease providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 36 | $65,248 |
| CeftriaxoneCeftriaxone Sodium | 68 | $25,725 |
| ErtapenemErtapenem Sodium | 21 | $10,538 |
| Vancomycin Hcl | 45 | $9,307 |
| Cefepime Hcl | 29 | $5,339 |
| Imipenem-Cilastatin SodiumImipenem/Cilastatin Sodium | 14 | $3,011 |
| Cefazolin Sodium | 13 | $1,033 |
| Doxycycline Hyclate | 22 | $503 |
| Cephalexin | 12 | $442 |
| Cefdinir | 16 | $435 |
| Azithromycin | 13 | $305 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $103 |
| Amoxicillin | 12 | $98 |
| Fluconazole | 11 | $62 |
| Penicillin V Potassium | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Delmar
- Deborah KahalWilmington$109K
- Jimmy ChuaLewes$18K
- Kirsten HauerWilmington$9K
- Ramesh VemulapalliDover$4K
- Wesley EmmonsNewark$4K
- William MazurWilmington$3K
- Maya GuptaNewark$2K
- John PiperNewark$1K
- Ambreen RazaMilford$1K
- William ChasanovLewes$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.